In this study, we employed a series of bioinformatics methods, combining Limma differential analysis and WGCNA, to analyze three airway epithelial cell microarray datasets from the GEO database (GSE10006, GSE11906, and GSE20257). We identified four ferroptosis-related hub genes (NQO1, AKR1C3, CBR1, and GPX2) that were consistently upregulated in the COPD group. Among these four ferroptosis-related genes, AKR1C3 and NQO1 are ferroptosis suppressor genes, while GPX2 is classified as a ferroptosis marker gene. CBR1 is categorized as an unclassified ferroptosis-related gene [29]. Importantly, AKR1C3 and NQO1 are both ROS detoxification enzymes. This finding was further confirmed through validation with the GSE11784 dataset and in vitro experiments (western blot and qPCR), which validated the high expression trend of these ferroptosis-related hub genes in COPD patients. To elucidate the role of these four ferroptosis-related DEGs in COPD, KEGG pathway and GO analyses were conducted.
Chronic obstructive pulmonary disease (COPD) is characterized by airway inflammation, irreversible airflow obstruction, and destruction of the lung parenchyma or emphysema [30]. COPD ranks as the third leading cause of morbidity and mortality worldwide [31]. The pathogenesis of COPD is incompletely understood but involves oxidative stress, protease/antiprotease imbalance, and an abnormal inflammatory response to harmful gases such as cigarette smoke (CS), which are major risk factors for this disease [32]. A study analyzing bronchoalveolar lavage fluid from rats exposed to cigarette smoke and COPD patients revealed that cigarette smoke particles may alter iron homeostasis, trigger metal accumulation, affect oxidative stress and inflammation, and contribute to lung damage in smokers with COPD [33]. Since ferroptosis was discovered in 2012, it has received widespread attention[34]. As ferroptosis progresses, intracellular iron stores decrease, leading to an increase in Fe²⁺ levels. Excess Fe²⁺ catalyzes the Fenton reaction, producing large amounts of ROS, hydroxyl radicals, and other oxidative species. These oxidative species may bind to polyunsaturated fatty acids, resulting in substantial lipid peroxidation. Iron chelators, such as the ferroptosis inhibitor Fer1, can reduce iron levels and lipid peroxidation, thereby inhibiting ferroptosis[35, 36].
The Limma R package offers a comprehensive solution for analyzing gene expression data[37]. WGCNA, a systems biology technique for analyzing gene association patterns between samples, was used to construct gene coexpression networks and identify related gene clusters, calculating the correlations between gene modules and phenotypes. We identified 1950 significant module genes and used Limma analysis and WGCNA to screen for connecting genes, shared genes, and related gene clusters associated with COPD and ferroptosis. The intersection of ferroptosis-related hub genes (n = 5) and COPD-associated module genes (n = 1950) revealed four common risk genes related to both COPD and ferroptosis. We subsequently performed GSEA to identify functional enrichments between COPD smokers and nonsmoking healthy individuals. Next, we generated ROC curves using data from COPD patients and healthy controls. The results indicate that the AUC values of these 4 hub genes (NQO1, AKR1C3, CBR1, and GPX2) in three gene sets (GSE10006, GSE11906, and GSE20257) are greater than 0.9 (AUC > 0.6 indicates diagnostic significance). These findings demonstrate the significant diagnostic value of NQO1, AKR1C3, CBR1, and GPX2 for COPD. We subsequently conducted immune infiltration analysis, and the results revealed that the expression of the 4 hub genes was positively correlated with immune cell infiltration. A type 2 microenvironment enriched with eosinophils in spatially restricted areas has been identified in COPD [38]. The proportion of T cells in the lungs of current smokers and COPD patients decreases, whereas the proportion of macrophages increases [39]. The responses of macrophages to various tissue microenvironments and external stimuli are plastic [40]. We found a significant increase in the proportion of M2 macrophages, which primarily participate in anti-inflammatory responses. In the COPD group, there was a notable increase in the number of M2 macrophages, suggesting their potential role in the pathogenesis of COPD. Finally, we utilized the Enrichr platform with the DsigDB database to predict target drugs for the selected hub genes (NQO1, AKR1C3, CBR1, GPX2). The top 10 drugs were identified on the basis of comprehensive scoring. Among them, acetaminophen and glycidamide are noted for their high research value and clinical significance in the treatment of COPD.
GPX2 is a major isoform of cigarette smoke-induced pulmonary glutathione peroxidase (GPX) and is regulated by nuclear factor erythroid 2-related factor 2 (Nrf2). Its primary function is to detoxify hydrogen peroxide or organic hydroperoxides, thereby protecting biological membranes and cellular components from oxidative stress[41]. Tian et al. demonstrated that knockdown of GPX2 partially reversed the increase in lipid ROS and iron levels induced by erastin, supporting the potential role of GPX2 as a driver of ferroptosis [42]. Moreover, NQO1 is a multifunctional antioxidant enzyme that plays a crucial role in protecting cells from oxidative damage through proteasomal degradation, exogenous detoxification, p53 regulation, superoxide scavenging, and maintenance of endogenous antioxidants [43]. CBR1 is a widely expressed NADPH-dependent enzyme belonging to the short-chain reductase/dehydrogenase family, which catalyzes the reduction of a broad range of exogenous and endogenous carbonyl compounds, and existing studies suggest that chrysin, a CBR1 inhibitor, can induce ferroptosis by targeting and inhibiting CBR1[44]. Additionally, AKR1C3 has been shown to participate in the detoxification of toxic lipid metabolites produced from the oxidation of various polyunsaturated fatty acids, such as 4-hydroxynonenal [45].
This study ultimately identified 4 hub genes associated with ferroptosis (NQO1, AKR1C3, GPX2, and CBR1), providing important insights for the diagnosis, treatment, and targeted drug screening of COPD. However, the study relied primarily on bioinformatics analysis, with validation through in vitro experiments. Data were sourced from the DEO database, which lacks sufficient COPD-related information, thereby presenting certain limitations. Future research could involve the construction of animal models for in vivo experimental validation and further exploration of the mechanisms of ferroptosis in COPD.